BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
80 hedge funds and large institutions have $23.7M invested in bluebird bio in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 3 increasing their positions, 61 reducing their positions, and 72 closing their positions.
Holders
80
Holders Change
-58
Holders Change %
-42.03%
% of All Funds
1.07%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
16
Increased
3
Reduced
61
Closed
72
Calls
$40.7M
Puts
$4.89M
Net Calls
+$35.8M
Net Calls Change
+$36M
Top Buyers
Top Sellers
1 |
1
BlackRock
New York
|
$5.91M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$4.38M |
3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$1.95M |
4 |
4
State Street
Boston,
Massachusetts
|
$1.65M |
5 |
![]()
5
Fidelity Investments
Boston,
Massachusetts
|
$397K |